entertainment -WSS

entertainment

author：comprehensive 2025-09-30 01:02:59 - browse：254

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： The aspartame in Diet Coke probably isn’t giving you cancer

entertainment

hotspot

WSS

Wisconsin governor employs partial veto to fund schools for 4 centuries

Biden targets hefty hospital 'facility fees' that often surprise patients

PhRMA lawsuit over Medicare drug price negotiation tossed

KalVista pill reduced swelling 'attacks' caused by genetic disease

Gilead might be held responsible for not developing a drug

Wisconsin governor employs partial veto to fund schools for 4 centuries

Wikipedia

entertainment

leisure time

Bright Health sells Medicare Advantage business to Molina

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Bright Health sells Medicare Advantage business to Molina

Industry veterans launch new biotech VC with $310M

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pandemic and All Hazards Preparedness Act needs lean update

Medical records are filled with copy

KalVista pill reduced swelling 'attacks' caused by genetic disease

leisure time

Why did Pfizer dish out millions for a Super Bowl ad?

Medicare Advantage proposed rates disappoint insurers

Robert F. Kennedy is pitching centrism on health, even on abortion

Eisai exec who led development of Alzheimer’s drug to retire

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Gilead might be held responsible for not developing a drug

explore

entertainment

hotspot

hotspot